localized resectable neuroblastoma
Showing 1 - 25 of 3,087
Disseminated Neuroblastoma, Ganglioneuroblastoma, Localized Resectable Neuroblastoma Trial in United States (drug, radiation,
Active, not recruiting
- Disseminated Neuroblastoma
- +5 more
- cyclophosphamide
- +18 more
-
Birmingham, Alabama
- +22 more
Mar 3, 2022
Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Australia, Canada,
Completed
- Localized Resectable Neuroblastoma
- +4 more
- Clinical Observation
- +5 more
-
Birmingham, Alabama
- +103 more
Jan 4, 2023
Resectable Soft Tissue Sarcoma, Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IA Soft Tissue Sarcoma
Recruiting
- Resectable Soft Tissue Sarcoma
- +4 more
- Hypofractionated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Biliary Tract Tumors, Gallbladder Cancer, Cholangiocarcinoma Trial in Seoul (Durvalumab + Gem/Cis, Gem/Cis)
Active, not recruiting
- Biliary Tract Neoplasms
- +2 more
- Durvalumab + Gem/Cis
- Gem/Cis
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 30, 2023
Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma Trial in Worldwide
Active, not recruiting
- Localized Resectable Neuroblastoma
- +5 more
- Aldesleukin
- +6 more
-
Birmingham, Alabama
- +196 more
Dec 30, 2022
Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (drug,
Active, not recruiting
- Disseminated Neuroblastoma
- +4 more
- cyclophosphamide
- +14 more
-
Birmingham, Alabama
- +120 more
Mar 3, 2022
GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)
Not yet recruiting
- GastroEsophageal Cancer
-
Lyon, FranceCentre Léon Bérard
Dec 1, 2022
Ch14.18 in Younger Patients With High-Risk Neuroblastoma
Completed
- Localized Resectable Neuroblastoma
- +6 more
- Cytology Specimen Collection Procedure
- Pharmacological Study
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Sep 30, 2019
Pancreatic Ductal Adenocarcinoma Trial in Houston (Pembrolizumab, Folfirinox)
Recruiting
- Pancreatic Ductal Adenocarcinoma
-
Houston, Texas
- +1 more
Dec 15, 2022
Recurrent Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Stage I Skin Cancer Trial in Los Angeles,
Recruiting
- Recurrent Skin Squamous Cell Carcinoma
- +4 more
- Cemiplimab
- Resection
-
Los Angeles, California
- +2 more
Nov 12, 2022
Resectable Pancreatic Cancer Trial in Denmark (ctDNA)
Recruiting
- Resectable Pancreatic Cancer
- ctDNA
-
Aalborg, Denmark
- +4 more
Mar 27, 2023
Resectable Soft Tissue Sarcoma, Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IA Soft Tissue Sarcoma
Active, not recruiting
- Resectable Soft Tissue Sarcoma
- +7 more
- Hypofractionated Radiation Therapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 22, 2022
High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,
Recruiting
- High Risk Neuroblastoma
- +4 more
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +10 more
Jan 19, 2023
Pancreas Adenocarcinoma, Resectable Pancreatic Cancer Trial in Loma Linda (Gemcitabine 1000 mg, nab-paclitaxel, Stereotactic
Recruiting
- Pancreas Adenocarcinoma
- Resectable Pancreatic Cancer
- Gemcitabine 1000 mg
- +2 more
-
Loma Linda, CaliforniaLoma Linda University Health
Jun 14, 2022
Pancreatic Adenocarcinoma Trial in Evanston (5 Fluorouracil, Leucovorin, Irinotecan)
Completed
- Pancreatic Adenocarcinoma
- 5 Fluorouracil
- +3 more
-
Evanston, IllinoisNorthShore University HealthSystem
Nov 4, 2021
Localized Resectable Tumor, MSI/dMMR or EBV-positive Gastric Cancers Trial in France (Pembrolizumab)
Recruiting
- Localized Resectable Tumor
- MSI/dMMR or EBV-positive Gastric Cancers
-
Lyon, France
- +6 more
Apr 28, 2022
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (Carboplatin,
Recruiting
- Ganglioneuroblastoma
- +3 more
- Carboplatin
- +6 more
-
Birmingham, Alabama
- +219 more
Aug 17, 2022
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Houston (biological,
Active, not recruiting
- Prostate Adenocarcinoma
- +5 more
- Daratumumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Tumor Tissue Samples From Newly Diagnosed Neuroblastoma or
Recruiting
- Ganglioneuroblastoma
- +5 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +258 more
Mar 23, 2022
Pancreatic Cancer Non-resectable Trial in Amsterdam, Utrecht (stereotactic ablative radiotherapy)
Recruiting
- Pancreatic Cancer Non-resectable
- stereotactic ablative radiotherapy
-
Amsterdam, Noord-Holland, Netherlands
- +1 more
Feb 22, 2022
Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I
Recruiting
- Clinical Stage 0 Gastric Cancer AJCC v8
- +27 more
- Fluorouracil
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jul 5, 2022
Esophagus Cancer Trial in United States (Oxaliplatin, Docetaxel, Capecitabine)
Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Localized Non-Resectable Adult Liver Carcinoma Trial in
Completed
- Adult Hepatocellular Carcinoma
- +3 more
- Stereotactic Radiosurgery
-
Bronx, New YorkAlbert Einstein College of Medicine
Dec 6, 2021
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction
Not yet recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +9 more
- Atezolizumab
- +12 more
- (no location specified)
Apr 26, 2023
Pancreas Adenocarcinoma Trial in Leiden (Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101)
Not yet recruiting
- Pancreas Adenocarcinoma
- Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101
-
Leiden, NetherlandsLeiden University Medical Center
Aug 2, 2023